Gut-liver modulator shows promising type 2 diabetes control in phase 2 clinical trial
Researchers across 14 medical centers in China, including Peking University People's Hospital, have found that an investigational drug, berberine ursodeoxycholate (HTD1801), significantly lowered blood sugar levels and improved ...